Denmark· DK-28103681004
Levemir InnoLet
A insulin detemir product containing insulin detemir, registered in Denmark by Novo Nordisk A/S. The same ATC class is registered in 14 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Insulin detemir is registered in 14 of 19 countries.
Countries holding a registration under ATC A10AE05 (insulin detemir), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 9 of them publish a price we can compare per daily dose
Insulin detemir · ATC A10AE05
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Insulin detemir
- Manufacturer
- Novo Nordisk A/S
- Country
- Denmark (DK)
- ATC code
- A10AE05
- ATC class
- Insulin detemir
- Defined daily dose
- 40 E, P
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28103681004
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
434 interactions on record for insulin detemir.
Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Insulin detemir · interactions on record
434 records
- 15 severe
- 368 moderate
- 50 minor
Most severe, free to view
- SucralfateA02BX02moderate
- ThiethylperazinA04AB03moderate
- TriflupromazinA04AD06moderate
- PrednisoloneA07EA01moderate
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under A10AE05
Insulin detemir, as other registers publish it.
- SwitzerlandInsulin Levemir FlexPen
- SwitzerlandInsulin Levemir Penfill
- SwitzerlandInsulin NovoNordisk Levemir 100 E/ml FlexPen, InjektionslösungNovo Nordisk Pharma AG
- United StatesLevemirA-S Medication Solutions
- NorwayLevemirNovo Nordisk A/S
- United StatesLevemirA-S Medication Solutions
- PolandLevemirNovo Nordisk A/S
- NorwayLevemirNovo Nordisk A/S
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f2c980d7-7076-4c7a-8d77-3c34d393a703 GET /v1/drugs/f2c980d7-7076-4c7a-8d77-3c34d393a703?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "injektionsvæske, opløsning i fyldt pen",
"source": "dkma",
"strength": "100 E/ml",
"auth_role": "RAP",
"dk_drugid": "28103681004",
"substance": "Insulin detemir",
"auth_procedure": "Central",
"in_medicinpriser": false,
"registration_date_serial": "38139"
}See everything about insulin detemir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.